Exact Sciences to Participate in J.P. Morgan Healthcare Conference
02 1월 2025 - 8:00PM
Business Wire
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, today announced that company
management will participate in the following conference and invited
investors to participate by webcast.
- J.P. Morgan Healthcare Conference, San Francisco Presentation
followed by Q&A on Monday, January 13, 2025 at 1:30 p.m.
ET
The webcast can be accessed in the investor relations section of
Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences gives patients and health care professionals the
clarity needed to take life-changing action earlier. Building on
the success of the Cologuard® and Oncotype® tests, Exact Sciences
is investing in its pipeline to develop innovative solutions for
use before, during, and after a cancer diagnosis. For more
information, visit ExactSciences.com, follow Exact Sciences on X
@ExactSciences, or find Exact Sciences on LinkedIn and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250102318458/en/
Erik Holznecht Exact Sciences Corp.
investorrelations@exactsciences.com 608-800-6605
EXACT Sciences (NASDAQ:EXAS)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
EXACT Sciences (NASDAQ:EXAS)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
